320 related articles for article (PubMed ID: 8897973)
1. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Tang-Christensen M; Vrang N; Larsen PJ
Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
4. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.
Wang T; Edwards GL; Baile CA
Proc Soc Exp Biol Med; 1998 Oct; 219(1):85-91. PubMed ID: 9751227
[TBL] [Abstract][Full Text] [Related]
6. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
7. A role for glucagon-like peptide-1 in the central regulation of feeding.
Turton MD; O'Shea D; Gunn I; Beak SA; Edwards CM; Meeran K; Choi SJ; Taylor GM; Heath MM; Lambert PD; Wilding JP; Smith DM; Ghatei MA; Herbert J; Bloom SR
Nature; 1996 Jan; 379(6560):69-72. PubMed ID: 8538742
[TBL] [Abstract][Full Text] [Related]
8. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.
Kinzig KP; D'Alessio DA; Seeley RJ
J Neurosci; 2002 Dec; 22(23):10470-6. PubMed ID: 12451146
[TBL] [Abstract][Full Text] [Related]
9. Endogenous glucagon-like peptide-1 reduces drinking behavior and is differentially engaged by water and food intakes in rats.
McKay NJ; Galante DL; Daniels D
J Neurosci; 2014 Dec; 34(49):16417-23. PubMed ID: 25471579
[TBL] [Abstract][Full Text] [Related]
10. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
Schick RR; Zimmermann JP; vorm Walde T; Schusdziarra V
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1427-35. PubMed ID: 12776726
[TBL] [Abstract][Full Text] [Related]
11. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.
Meeran K; O'Shea D; Edwards CM; Turton MD; Heath MM; Gunn I; Abusnana S; Rossi M; Small CJ; Goldstone AP; Taylor GM; Sunter D; Steere J; Choi SJ; Ghatei MA; Bloom SR
Endocrinology; 1999 Jan; 140(1):244-50. PubMed ID: 9886831
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
[TBL] [Abstract][Full Text] [Related]
14. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
[TBL] [Abstract][Full Text] [Related]
15. Effects of peripheral or central GLP-1 receptor blockade on leptin-induced suppression of appetite.
Nowak A; Bojanowska E
J Physiol Pharmacol; 2008 Sep; 59(3):501-10. PubMed ID: 18953093
[TBL] [Abstract][Full Text] [Related]
16. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
[TBL] [Abstract][Full Text] [Related]
18. Effects of substitution of N-terminal amino acid of glucagon-like peptide-1 (7-36) amide on food intake of the neonatal chick.
Bungo T; Shimojo M; Masuda Y; Saito N; Sugahara K; Hasegawa S; Furuse M
Life Sci; 1999; 65(24):PL295-9. PubMed ID: 10619374
[TBL] [Abstract][Full Text] [Related]
19. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain.
Van Dijk G; Thiele TE; Donahey JC; Campfield LA; Smith FJ; Burn P; Bernstein IL; Woods SC; Seeley RJ
Am J Physiol; 1996 Oct; 271(4 Pt 2):R1096-100. PubMed ID: 8898006
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular glucagon-like peptide-1 (7-36) amide inhibits sham feeding in rats without eliciting satiety.
Asarian L; Corp ES; Hrupka B; Geary N
Physiol Behav; 1998 Jun; 64(3):367-72. PubMed ID: 9748106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
